webinar register page

Webinar banner
Combatting Malaria: New horizon of vaccines and drug discovery by young pharmaceutical scientists
Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.
In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.

1. Describe the development of malaria vaccine candidates.
2. Define seroepidemiology of malaria
3. Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.

Moderators:
-Dr Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University - Japan
-Dr Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry-United Kingdom

Panelists:
-Dr Eizo Takashima,Associate Professor, Ehime University-Japan
-Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo-US
-Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University-Japan
-Khalid Garba Mohammed, Lecturer, Bayero University, Kano-Nigeria
* Required information
Loading

Speakers

Takuya Kumamoto
Professor @Hiroshima University
Prof Kumamoto graduated Faculty of Pharmaceutical Sciences, Kanazawa University, and obtained his PhD at University of Tokyo , 1996, studying development of enantioselective reaction using chiral 2-aminoalkoxides. After pursuing hist post doc at Nagoya University for one year, he was promoted to assistant professor of department of Faculty of Pharmaceutical Sciences, Chiba University in 1997. He also joined Département de Chimie,, Universite catholique de Louvain as post doc (2001-2002). After promoted to lecturer and associate professor in same department, he moved to Faculty of Pharmacy, Musashino University as Professor in 2010, and to the present position in 2017. His main research topic is about synthetic study of bioactive natural products. He joined FIP in 2012 as a chair of FIP BPS Special Interest Group Drug Design and Discovery, which was succeeded to SIG New Medicines. He was elected as a FIP Fellow in 2017.
Rebecka Isaksson
Postdoctoral Research Associate @UCL Department of Chemistry
Rebecka is a postdoc at UCL Department of Chemistry, with a current research focus on delivery of antimicrobial peptides to Gram-negative bacteria. She received her PhD in Pharmaceutical Sciences at Uppsala university in 2019, and has previously obtained a Master of Science and Engineering in chemistry from KTH in Stockholm. She also serves as the Chair of FIP’s special interest group “New Generation of Pharmaceutical Scientists”.
Eizo Takashima
Associate Professor @Ehime University
Ph. D. University of Tokyo (2002) 2002-2003 Banyu Pharmaceutical Co 2003-2007 Research Associate, The Nippon Dental University 2007-2010 Assistant Professor, The Nippon Dental University 2009-2011 Visiting scientist, the Institut Pasteur 2011 Senior research associate, University of Minnesota 2011-2013 Associate Professor, Division of Proteomedical Sciences, Cell-Free Science and Technology Research Center, Ehime University 2013-present Associate Professor, Proteo-Science Center, Division of Malaria Research, Ehime University 2019-present Invited Associate Professor, Research Institute for Microbial Diseases, Osaka University
Wei-Chiao Huang
Post-doc @State University of New York at Buffalo
Dr. Wei-Chiao Huang received her BS degree from National Dong Hwa University and MS degree Biomedical Engineering from National Tsing Hua University in Taiwan. She has over seven years of working experience with various liposomal formulations for biomedical applications. During her PhD research in Biomedical Engineering at the State University of New York at Buffalo, she focused on vaccine development, antigen-liposome conjugation and preclinical animal studies for vaccine development for infectious disease research. Her present work is focused on the further development and translation of next-generation liposomal vaccine adjuvants.
Takaya Sakura
Assistant Professor @Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University
Biography (up to 1000 characters) 2019-present Assistant Professor, Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University 2017-2019 Postdoctoral Fellow, School of Tropical Medicine and Global Health, Nagasaki University 2016-2017 Postdoctoral Fellow Inserm U1016, C NRS UMR8104, Institut Cochin, Paris 75014 France. Laboratoire de Biologie Cellulaire Comparative des Apicomplexes, Faculté de Médecine, Université Paris Descartes Sorbonne Paris Cité, France. 2014-2016 Postdoctoral Fellow, Laboratory of Cellular and Molecular Biology of Toxoplasma, Université de Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, INSERM U 1019, CNRS UMR 8204, 59000, Lille, France. 2013-2014 Postdoctoral Fellow, National Institute of Infectious Diseases, Japan 2009-2013 Ph.D. in Biomedical Sciences, Nagasaki University, Japan 2007-2009 Master of Health Sciences, Kobe University, Japan 2003-2007 Bachelor of Health Sciences, Kobe Univ